TIAA Trust National Association Sells 83,542 Shares of Danaher Corporation $DHR

TIAA Trust National Association decreased its stake in shares of Danaher Corporation (NYSE:DHR) by 72.1% in the third quarter, HoldingsChannel reports. The institutional investor owned 32,262 shares of the conglomerate’s stock after selling 83,542 shares during the period. TIAA Trust National Association’s holdings in Danaher were worth $6,396,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. WFA of San Diego LLC bought a new stake in shares of Danaher during the second quarter valued at approximately $26,000. Howard Hughes Medical Institute purchased a new position in Danaher during the 2nd quarter worth $27,000. ANTIPODES PARTNERS Ltd purchased a new position in Danaher during the 3rd quarter worth $27,000. TruNorth Capital Management LLC bought a new stake in Danaher during the 3rd quarter valued at $28,000. Finally, Tripletail Wealth Management LLC bought a new position in shares of Danaher during the 3rd quarter worth $31,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president directly owned 5,099 shares of the company’s stock, valued at $1,060,642.99. This trade represents a 20.56% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 11.10% of the stock is currently owned by company insiders.

Danaher Stock Performance

Shares of DHR stock opened at $210.28 on Friday. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $242.80. The business’s fifty day simple moving average is $225.33 and its 200-day simple moving average is $216.23. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35. The company has a market cap of $148.70 billion, a PE ratio of 41.72, a PEG ratio of 2.85 and a beta of 0.91.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, topping the consensus estimate of $2.14 by $0.09. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The firm had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. During the same period in the previous year, the business earned $2.14 EPS. The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. Analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, March 27th. This is a positive change from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. Danaher’s payout ratio is presently 25.40%.

Analysts Set New Price Targets

Several research firms recently weighed in on DHR. Evercore restated an “outperform” rating and issued a $254.00 price objective on shares of Danaher in a report on Wednesday, January 28th. Morgan Stanley started coverage on shares of Danaher in a research report on Monday, December 1st. They set an “overweight” rating and a $270.00 target price on the stock. TD Cowen reaffirmed a “buy” rating on shares of Danaher in a research report on Wednesday, January 7th. The Goldman Sachs Group dropped their price objective on shares of Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 29th. Finally, Jefferies Financial Group boosted their price objective on shares of Danaher from $255.00 to $265.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Twenty analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $253.86.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.